Search for: "JANSSEN PHARMACEUTICALS PRODUCTS, L.P."
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
23 May 2012, 9:22 pm
Janssen Products, L.P. et al. v. [read post]
17 Jun 2012, 9:55 pm
Janssen Products, L.P. et al. v. [read post]
7 Oct 2013, 7:12 am
Janssen Phamaceutica Products, L.P. [read post]
7 Oct 2013, 7:12 am
Janssen Phamaceutica Products, L.P. [read post]
8 Jan 2009, 4:07 am
Ortho Biotech Products, L.P., 551 F. [read post]
6 Oct 2010, 11:43 pm
In an “intermediate” case – Dey L.P. and Dey Inc. v. [read post]
24 Feb 2011, 1:49 pm
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
24 Jun 2010, 5:00 am
Playtex Family Products Corp., 168 F.R.D. 292 (D. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
28 Apr 2011, 3:18 pm
Comment k says unavoidably unsafe products are “especially common” in the context of prescription medical products (actually, it says “drugs” but “medical devices” weren’t recognized as a separate category of products in the early 1960s – the Medical Device Amendments still being more than a decade in the future). [read post]
5 Jul 2007, 10:37 am
Purdue Pharma, L.P., 821 N.E.2d 141, 146 (Ohio 2004); Vaccariello v. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
20 Mar 2009, 2:05 am
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 (S.D. [read post]
2 Jun 2011, 12:46 pm
Purdue Pharma, L.P., 295 F. [read post]
10 Apr 2014, 11:58 am
Janssen Pharmaceuticals, Inc., 2014 WL 1335511 (Pa. [read post]
5 Feb 2009, 12:19 pm
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 664 (M.D. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
